(Q43134194)

14 November 2017

title

High level of serum undercarboxylated osteocalcin in patients with incident fractures during bisphosphonate treatment (English)

1 reference

14 November 2017

1 reference

Masataka Shiraki

1

1 reference

14 November 2017

Yasushi Yamazaki

2

1 reference

14 November 2017

Yumiko Shiraki

3

1 reference

14 November 2017

Takayuki Hosoi

4

1 reference

14 November 2017

Naoko Tsugawa

5

1 reference

14 November 2017

Toshio Okano

6

1 reference

14 November 2017

publication date

11 March 2010

1 reference

Journal of Bone and Mineral Metabolism

14 November 2017

published in

1 reference

14 November 2017

volume

28

1 reference

14 November 2017

issue

5

1 reference

14 November 2017

page(s)

578-584

1 reference

https://scigraph.springernature.com/pub.10.1007/s00774-010-0167-2

14 November 2017

exact match

0 references

cites work

Vitamin K2 regulation of bone homeostasis is mediated by the steroid and xenobiotic receptor SXR.

1 reference

12 December 2020

Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis The Study of Osteoporotic Fractures Research Group

1 reference

12 December 2020

Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate.

1 reference

12 December 2020

Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis.

1 reference

12 December 2020

Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials

1 reference

12 December 2020

Diagnostic criteria for primary osteoporosis: year 2000 revision

1 reference

12 December 2020

The sample size required for intervention studies on fracture prevention can be decreased by using a bone resorption marker in the inclusion criteria: prospective study of a subset of the Nagano Cohort, on behalf of the Adequate Treatment of Osteopo

1 reference

12 December 2020

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group

1 reference

12 December 2020

Short-term menatetrenone therapy increases gamma-carboxylation of osteocalcin with a moderate increase of bone turnover in postmenopausal osteoporosis: a randomized prospective study

1 reference

12 December 2020

Response of serum carboxylated and undercarboxylated osteocalcin to alendronate monotherapy and combined therapy with vitamin K2 in postmenopausal women

1 reference

12 December 2020

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group

1 reference

12 December 2020

Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate.

1 reference

12 December 2020

Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy.

1 reference

12 December 2020

Pretreatment levels of bone turnover and the antifracture efficacy of alendronate: the fracture intervention trial

1 reference

12 December 2020

Conversion of phylloquinone (Vitamin K1) into menaquinone-4 (Vitamin K2) in mice: two possible routes for menaquinone-4 accumulation in cerebra of mice

1 reference

12 December 2020

Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras.

1 reference

12 December 2020

Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis

1 reference

12 December 2020

Biochemical markers of bone turnover: part I: biochemistry and variability

1 reference

12 December 2020

Vitamin K treatment reduces undercarboxylated osteocalcin but does not alter bone turnover, density, or geometry in healthy postmenopausal North American women

1 reference

12 December 2020

Low plasma phylloquinone concentration is associated with high incidence of vertebral fracture in Japanese women.

1 reference

12 December 2020

A double-masked multicenter comparative study between alendronate and alfacalcidol in Japanese patients with osteoporosis. The Alendronate Phase III Osteoporosis Treatment Research Group

1 reference

12 December 2020

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

1 reference

12 December 2020

Japanese fermented soybean food as the major determinant of the large geographic difference in circulating levels of vitamin K2: possible implications for hip-fracture risk

1 reference

12 December 2020

Association of bone mineral density with apolipoprotein E phenotype

1 reference

12 December 2020

10.1007/S00774-010-0167-2

Identifiers

DOI

1 reference

Dimensions Publication ID

14 November 2017

1041176248

0 references

1 reference